Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20337305 | 1.00 | GABRA1 (0.44) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7184928 | 0.98 | GABRA1 (0.43) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7176645 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7176933 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL20339586 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7182146 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7177112 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7177221 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| Hydrochloric Acid SCHEMBL7182609 | 0.96 | GABRA1 (0.42) | GABRA1GABRB2PKMELANEALDH1A1 | |
| SCHEMBL20339587 | 0.93 | GABRA1 (0.40) | GABRA1GABRB2PKMELANEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562799-B1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2023-08-23 | — | — | EP | claimed |
| US-10793489-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-10-06 | — | — | US | claimed |
| US-10604457-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-03-31 | — | — | US | claimed |
| US-20200095178-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2020-03-26 | — | — | US | claimed |
| EP-3562799-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2019-11-06 | — | — | EP | claimed |
| EP-3562800-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2019-11-06 | — | — | EP | claimed |
| US-20190276377-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-09-12 | — | — | US | claimed |
| US-10407360-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-09-10 | — | — | US | claimed |
| US-20190194089-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-06-27 | — | — | US | claimed |
| WO-2018128861-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-07-12 | — | — | WO | claimed |
| US-20180186709-A1 | Ethylene Oligomerizaton Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-07-05 | — | — | US | claimed |
| WO-2018125826-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-07-05 | — | — | WO | claimed |
| EP-3562799-B1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11358914-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2022-06-14 | — | — | US | disclosed |
| US-20210214289-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2021-07-15 | — | — | US | disclosed |
| US-10793489-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-10-06 | — | — | US | disclosed |
| US-20180186708-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-07-05 | — | — | US | disclosed |
| US-20180186709-A1 | Ethylene Oligomerizaton Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-07-05 | — | — | US | disclosed |
| US-20080021180-A1 | CHROMIUM CATALYSTS ACTIVE IN OLEFIN POLYMERIZATION | REPSOL QUIMICA, S.A. | 2008-01-24 | — | — | US | disclosed |
| US-20080021180-A1 | CHROMIUM CATALYSTS ACTIVE IN OLEFIN POLYMERIZATION | REPSOL QUIMICA, S.A. | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180186708-A1 | Ethylene Oligomerization Processes | MAX, AP1M1, AP2M1 | GABRA1 2569/4885GABRB2 2213/4885PKM 273/4885 |
| US-20190276377-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | GABRA1 1054/4885GABRB2 1093/4885PKM 3481/4885 |
| US-20190194089-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | GABRA1 1054/4885GABRB2 1093/4885PKM 3481/4885 |
| US-10793489-B2 | Ethylene oligomerization processes | NOD2, AP1M1, AP2M1 | GABRA1 1054/4885GABRB2 1093/4885PKM 3481/4885 |
| US-10604457-B2 | Ethylene oligomerization processes | EPS15, PICALM, AP2M1 | GABRA1 2407/4885GABRB2 2726/4885PKM 1319/4885 |
| US-10407360-B2 | Ethylene oligomerization processes | NOD2, AP1M1, AP2M1 | GABRA1 1054/4885GABRB2 1093/4885PKM 3481/4885 |
| US-20200095178-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | GABRA1 1054/4885GABRB2 1093/4885PKM 3481/4885 |
| US-20180186709-A1 | Ethylene Oligomerizaton Processes | PICALM, EPS15, EPN1 | GABRA1 2117/4885GABRB2 2665/4885PKM 1101/4885 |
| US-20210214289-A1 | Ethylene Oligomerization Processes | MAX, AP1M1, AP2M1 | GABRA1 2569/4885GABRB2 2213/4885PKM 273/4885 |
| US-11358914-B2 | Ethylene oligomerization processes | MAX, AP1M1, AP2M1 | GABRA1 2569/4885GABRB2 2213/4885PKM 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.